The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorNational Taiwan University Hospital
About this trial
This study aims to examine the effects of a lifestyle intervention based on a health belief model (HBM) supported by mobile health (mHealth) and the impact of continuous glucose monitoring (CGM) on maternal glycemic parameters, cardiometabolic risk, health behavior and infant's outcomes among women diagnosed with gestational diabetes mellitus (GDM).
Eligibility criteria
Qualifiers
Aged 18 years or above
Pregnant women diagnosed with gestational diabetes mellitus
Willing to participate in the study
Disqualifiers
Diagnosed with diabetes mellitus before pregnancy
Allergic to materials such as tapes (e.g., redness, swelling, itching, pain, blisters, or rashes caused by breathable tapes or patches)
Abnormal coagulation function
Trial design
Treatments tested in this trial
- Continuous glucose monitor
- Perinatal nursing care for gestational diabetes
- Blood glucose meters (BGM)
Treatment groups
120 Participants
are divided into 3 treatment groupsLocations
1National Taiwan University Hospital Hsin-Chu Branch BioMedical Park Hospital302058, Hsinchu Taiwan
Sponsors and collaborators
National Taiwan University Hospital
Lead sponsor
Source ClinicalTrials.gov